By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, Stichoposide D inhibits growth of leukemia xenografts

Documenti analoghi

• In vitro and in vivo anti-leukemic effects of cladoloside C(2) are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH(2)-terminal kinase/caspase-8
  di: Yun, Seong-Hoon, et al.
  Pubblicazione: (2017)
• Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia
  di: Yun, Seong-Hoon, et al.
  Pubblicazione: (2016)
• Organization and Dynamics of Fas Transmembrane Domain in Raft Membranes and Modulation by Ceramide
  di: Castro, Bruno M., et al.
  Pubblicazione: (2011)
• Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia
  di: Verlekar, Dattesh, et al.
  Pubblicazione: (2018)
• The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells
  di: Park, Seon-Joo, et al.
  Pubblicazione: (2005)